Page last updated: 2024-11-05

trifluoperazine and Diabetes Mellitus, Type 2

trifluoperazine has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Levy, J1
Gavin, JR1
Hammerman, MR1
Avioli, LV1

Other Studies

1 other study available for trifluoperazine and Diabetes Mellitus, Type 2

ArticleYear
Ca2+-Mg2+-ATPase activity in kidney basolateral membrane in non-insulin-dependent diabetic rats. Effect of insulin.
    Diabetes, 1986, Volume: 35, Issue:8

    Topics: Animals; Basement Membrane; Ca(2+) Mg(2+)-ATPase; Calcium; Calcium-Transporting ATPases; Diabetes Me

1986